Quince Therapeutics 주식 가격. QNCX - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

1.93

매수가

1.85

매도가

1.99

거래량

166,307

1.84 일간 변동폭 1.97

0.5116 52주 범위 2.45

market_cap

84.923M

전일 종가

1.84

개장가

1.95

최근 거래 시간

850

1.93

(formt)

마지막 거래 시간

재정 규모

US$ 315,580

VWAP

1.8976

평균 볼륨(3m)

594,771

발행 주식

44,001,643

배당수익률

주가수익률

-2.73

주당순이익(EPS)

-0.71

매출

순이익

-31.39M

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

quincetx.com

본부

Wilmington, Delaware, USA

설립됨

Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker QNCX. The last closing price for Quince Therapeutics was US$1.84. Over the last year, Quince Therapeutics shares have traded in a share price range of US$ 0.5116 to US$ 2.45.

Quince Therapeutics currently has 44,001,643 shares in issue. The market capitalisation of Quince Therapeutics is US$80.96 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.73.

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Phase 3 NEAT clinical trial on track with 32 patients enrolled to date with majority of U.S. and European study sites now enrolling patients Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage...

Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the...

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.06	-3.01507537688	1.99	2.1097	1.8	198786	1.95003304	CS
4	0.16	9.0395480226	1.77	2.45	1.68	286764	1.98315659	CS
12	1.15	147.435897436	0.78	2.45	0.69	594771	1.42749925	CS
26	1.23	175.714285714	0.7	2.45	0.5116	361383	1.24055519	CS
52	0.7	56.9105691057	1.23	2.45	0.5116	226021	1.20523961	CS
156	-10	-83.8222967309	11.93	14.6	0.5116	476964	2.60178503	CS
260	-40.36	-95.4362733507	42.29	121.98	0.5116	459969	13.70801765	CS

QNCX - Frequently Asked Questions (FAQ)

What is the current Quince Therapeutics share price?

The current share price of Quince Therapeutics is US$ 1.93

How many Quince Therapeutics shares are in issue?

Quince Therapeutics has 44,001,643 shares in issue

What is the market cap of Quince Therapeutics?

The market capitalisation of Quince Therapeutics is USD 80.96M

What is the 1 year trading range for Quince Therapeutics share price?

Quince Therapeutics has traded in the range of US$ 0.5116 to US$ 2.45 during the past year

What is the PE ratio of Quince Therapeutics?

The price to earnings ratio of Quince Therapeutics is -2.73

What is the reporting currency for Quince Therapeutics?

Quince Therapeutics reports financial results in USD

What is the latest annual profit for Quince Therapeutics?

The latest annual profit of Quince Therapeutics is USD -31.39M

What is the registered address of Quince Therapeutics?

The registered address for Quince Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Quince Therapeutics website address?

The website address for Quince Therapeutics is quincetx.com

Which industry sector does Quince Therapeutics operate in?

Quince Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
LITMSnow Lake Resources Ltd	US$ 0.7943 (334.04%)	1.2B
NUKKNukkleus Inc	US$ 50.68 (326.60%)	54.52M
PLRZPolyrizon Ltd	US$ 3.256 (210.10%)	137.32M
QMCOQuantum Corporation	US$ 60.085 (153.31%)	22.66M
VRARGlimpse Group Inc	US$ 3.1885 (100.53%)	55.04M
XCHXCHG Ltd	US$ 2.16 (-90.74%)	11.2M
FTELFitell Corporation	US$ 5.50 (-85.67%)	1.69M
XHGXChange TED Inc	US$ 0.754 (-52.28%)	549.39k
MHUAMeihua International Medical Technologies Company Ltd	US$ 0.2755 (-43.82%)	8.86M
RNAZTransCode Therapeutics Inc	US$ 3.915 (-38.00%)	860.08k
LITMSnow Lake Resources Ltd	US$ 0.7943 (334.04%)	1.2B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.3671 (9.94%)	317.96M
CGTXCognition Therapeutics Inc	US$ 0.58295 (28.15%)	287.37M
RGTIRigetti Computing Inc	US$ 10.684 (-4.01%)	280.37M
NVDANVIDIA Corporation	US$ 128.91 (-1.14%)	277.36M